Iwane, K., Nakanishi, Y., Muta, Y., Chen, J., Yasumura, K., Omatsu, M., Aoyama, N., Ikeda, M., Masui, Y., Cai, L., Yamakawa, G., Hamada, K., Mizukoshi, K., Kawai, M., Iimori, K., Nakayama, S., Agatsuma, N., Utsumi, T., Nagao, M., Maruno, T., Hiramatsu, Y., Kakiuchi, N., Nakagawa, M. M., Fukui, Y., Kusunoki, Y., Kasashima, H., Fujimoto, M., Itatani, Y., Kogame, T., Fukuda, A., Yashiro, M., Maeda, K., Kabashima, K., Obama, K., Ogawa, S., Diaz-Meco, M. T., Moscat, J., Seno, H. (2025). Targeting fibroblast derived thrombospondin 2 disrupts an immune-exclusionary environment at the tumor front in colorectal cancer. Nature Communications. https://doi.org/10.1038/s41467-025-66485-2